Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M004549200 on August 7, 2000

J. Biol. Chem., Vol. 275, Issue 45, 35442-35447, November 10, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/45/35442    most recent
M004549200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, J.
Right arrow Articles by Siraganian, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, J.
Right arrow Articles by Siraganian, R. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Phosphorylation of Syk Activation Loop Tyrosines Is Essential for Syk Function

AN IN VIVO STUDY USING A SPECIFIC ANTI-Syk ACTIVATION LOOP PHOSPHOTYROSINE ANTIBODY*

Juan ZhangDagger §, Melvin L. Billingsley, Randall L. Kincaid, and Reuben P. SiraganianDagger

From the Dagger  Receptors and Signal Transduction Section, Oral Infection and Immunity Branch, NIDCR, National Institutes of Health, Bethesda, Maryland 20892 and the  Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033

Received for publication, May 25, 2000, and in revised form, August 1, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Syk is an important protein-tyrosine kinase in immunoreceptor signaling. Fcepsilon RI aggregation in mast cells induces tyrosine phosphorylation and increased enzymatic activity of Syk. The two adjacent tyrosines in the Syk activation loop are thought to be important for the propagation of Fcepsilon RI signaling. To evaluate the phosphorylation of these tyrosines in vivo and further understand the relationship of Syk tyrosine phosphorylation with its function, an antibody was developed specific for phosphorylated tyrosines in the activation loop of Syk. Fcepsilon RI aggregation on mast cells induced the phosphorylation of both tyrosine residues of the activation loop. The kinase activity of Syk played the major role in phosphorylating its activation loop tyrosines both in vivo and in vitro. In Fcepsilon RI-stimulated mast cells, the total Syk tyrosine phosphorylation paralleled the phosphorylation of its activation loop tyrosines and downstream propagation of signals for histamine release. In contrast, the cell surface binding of anti-ganglioside monoclonal antibody AA4 induced only strong general tyrosine phosphorylation of Syk and minimal histamine release and weak phosphorylation of activation loop tyrosines. These results demonstrate that phosphorylation of the activation loop tyrosines is important for mediating receptor signaling and is a better marker of Syk function than is total Syk tyrosine phosphorylation.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Aggregation of the high affinity IgE receptor, Fcepsilon RI, on mast cells results in release of mediators that initiate inflammatory and allergic responses (1, 2). The signal transduction pathway initiated by this receptor has many similarities to those of antigen receptors on T or B cells. These immune receptors lack intrinsic tyrosine kinase activity but possess signal-transducing subunits that contain the immunoreceptor tyrosine-based activation motif (ITAM)1 (3-6). Antigen stimulation induces rapid phosphorylation of tyrosines in the ITAM, which then recruit a Syk family tyrosine kinase from the cytoplasm to the membrane. The binding of Syk to the phosphorylated ITAM induces a conformational change in Syk, which results in its activation and tyrosine phosphorylation (7-16).

Accumulated data suggests that Syk is essential in mediating Fcepsilon RI signaling, which is further confirmed by the experiments using Syk-deficient mast cells (17-22). In these Syk-deficient cells, antigen stimulation does not induce cellular protein tyrosine phosphorylation, calcium mobilization, or degranulation, and these defects are reconstituted by the expression of Syk. Syk family tyrosine kinases are also important for signaling from other immunoreceptors such as the Fcgamma receptors and T or B cell receptors (23-28). Phosphopeptide mapping has identified 10 tyrosine residues in Syk that are autophosphorylated after an in vitro kinase reaction (29). Phosphorylation at these tyrosine residues may provide binding sites for substrates or may be important for regulating the catalytic activity of Syk. Indeed, phosphorylation of Tyr317 of Syk negatively down-regulates signal transduction in mast cells, probably by a pathway that involves Cbl, a negative regulator of protein tyrosine kinases (30-33). Similarly, the tyrosine residues in the activation loop of Syk (Tyr519 and Tyr520 in rat Syk) are essential for propagating downstream signaling events (34-36). These results suggest that tyrosine phosphorylation is a critical feature for regulating Syk enzymatic activity and for its function.

Structural studies suggest that activation loop tyrosines are important for regulating the enzymatic activity of many kinases. In the nonactivated state, these tyrosines occupy the catalytic center and hinder ATP and/or substrate binding. Phosphorylation of one or both of the tyrosines induces a conformational change that moves the loop out of the catalytic site, thereby allowing the binding of ATP and/or substrate. Therefore, the phosphorylation of these activation loop tyrosines is thought to regulate enzymatic activation. The crystal structure of the enzymatic domain of Syk or ZAP70 has not been established, although data suggest that a similar model also applies to these kinases. For example, mutants of Syk with the activation loop tyrosines mutated fail to signal from antigen receptors although there is no loss of in vitro enzymatic activity (34, 36).

There are still unresolved questions in understanding the relationship of Syk tyrosine phosphorylation with its function. For example, in the RBL-2H3 mast cell line both Fcepsilon RI stimulation and the cell surface binding of anti-ganglioside mAb AA4 induce similar levels of Syk tyrosine phosphorylation. However, the response of the cell to these two stimulants is dramatically different. Whereas Fcepsilon RI aggregation results in degranulation, mAb AA4 binding induces only minor, if any, histamine release (37). Therefore, examination of the phosphorylation of individual tyrosine residues will be necessary to better understand the function of Syk and the signal transduction pathways.

In the present study, a polyclonal antibody was developed that specifically detected the phosphorylation of the Syk activation loop tyrosines. This antibody, in combination with synthetic phosphopeptides, can distinguish the phosphorylation status of each of the two adjacent tyrosine residues. We compared the Fcepsilon RI- and mAb AA4-induced histamine release with the total and activation loop tyrosine phosphorylation of Syk. The results demonstrate that Syk activation loop tyrosine phosphorylation is directly related to the capacity of Syk to propagate downstream intracellular signals. Our experiments also suggest that, in vivo, both tyrosine residues in the Syk activation loop were phosphorylated after Fcepsilon RI stimulation. Furthermore, Syk kinase activity played the major role in phosphorylating these two tyrosines.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials and Antibodies-- Triton X-100 and protein A-agarose beads were obtained from Sigma. The materials for electrophoresis were from Novex (San Diego, CA). The horseradish peroxidase-conjugated anti-phosphotyrosine antibody 4G-10 was from Upstate Biotechnology, Inc. (Lake Placid, NY). The anti-ganglioside monoclonal antibody AA4, mouse and rabbit anti-Syk antibody, and other materials not indicated were as described previously (21, 38). The rabbit anti-Syk antibody was raised to a sequence in the linker region between the second SH2 domain and the kinase region and has been characterized previously (8).

Anti-Syk Activation Loop Phosphospecific Antibody-- Peptides were synthesized using a Milligen model 9500 peptide synthesizer. The parent peptide NH2-ALRADENYYKAQTHGC-COOH, corresponding to the activation loop of rat Syk amino acid sequence 512-526, was made using 9-fluorenylmethoxycarbony chemistry, with a cysteine COOH-terminal resin. For mono- and diphosphorylated peptides, a phosphorylated derivative of tyrosine was used instead of Tyr. Rabbits were immunized with the conjugate of the diphosphorylated peptide coupled to keyhole limpet hemocyanin (Sigma) via the COOH-terminal cysteine residue using m-maleimido-benzoyl-N-hydroxysuccinimide as a cross-linking reagent. The phosphopeptide-specific sera were purified by negative absorption with CH-Sepharose affinity beads containing the native, nonphosphorylated peptide.

Cell Culture and Activation-- Rat basophilic leukemia RBL-2H3 cells, Syk-negative variant TB1A2 cells, and their wild-type or activation loop tyrosine mutant transfectants (Y519F mutant, Y520F mutant, and Y519F/Y520F mutant) have been described previously (21, 36). A point mutation of Lys396 to Arg (dead kinase) was prepared by using a polymerase chain reaction-based method and confirmed by DNA sequencing. The dead kinase cDNA was cloned into pSVL expression vector and stably expressed in Syk-negative TB1A2 cells as described previously (21).

For Fcepsilon RI activation, the monolayers were cultured overnight either without or with antigen-specific IgE. The cells cultured with IgE were stimulated with the antigen at concentrations from 0.01 to 1.0 µg/ml. In some experiments, cells cultured without IgE were stimulated with different concentrations of AA4 antibody. After stimulation for the indicated times, the supernatants were removed for histamine analysis. For pervanadate stimulation, cells cultured without IgE were stimulated with 0.4 mM pervanadate for 30 min at 37 °C.

Immunoprecipitation and Immunoblotting-- After stimulation, the cell monolayers were rinsed with ice-cold PBS containing 2 mM Na3VO4, and protease inhibitors (2 mM phenylmethylsulfonyl fluoride, 90 milliunits/ml aprotinin, 50 µg/ml leupeptin, 50 µg/ml pepstatin) and solubilized in Triton lysis buffer (1% Triton, 20 mM Tris, pH 7.4, 100 mM NaCl, 50 mM NaF plus protease inhibitors and Na3VO4). The postnuclear supernatants were immunoprecipitated with rabbit anti-Syk antibody bound to protein A-agarose beads. After rotation at 4 °C for 1 h, the beads were washed four times with ice-cold lysis buffer, and the proteins were eluted by boiling for 5 min with SDS-polyacrylamide gel electrophoresis sample buffer as described previously (11). Whole cell lysates or immunoprecipitated proteins were separated by SDS-polyacrylamide gel electrophoresis and electrotransferred to polyvinylidene difluoride membranes (Millipore, Bedford, MA). The blots were probed with anti-phosphotyrosine mAb 4G10, anti-Syk activation loop phosphotyrosine antibody (anti-phospho-AL-Syk), or mouse anti-Syk antibody. In all blots, proteins were visualized by enhanced chemiluminescence (Renaissance).

In Vitro Kinase Assay-- Syk immunoprecipitated from nonstimulated cells was further washed with kinase buffer (30 mM HEPES, pH 7.5, 10 mM MgCl2, and 2 mM MnCl2) and resuspended in 25 µl of this kinase buffer. The kinase reactions were at 4 °C with 5 µM ATP and with or without diphosphorylated gamma -ITAM peptide in the reaction solution. The reactions were stopped by the addition of 25 µl of 2× Laemmli sample buffer and boiling for 10 min. The eluted proteins were separated under reducing conditions by SDS-polyacrylamide gel electrophoresis, electrotransferred to membranes, and blotted by anti-phosphotyrosine mAb 4G10, anti-phospho-AL-Syk, or mouse anti-Syk antibody. In all blots, proteins were visualized by enhanced chemiluminescence (Renaissance).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Generation of Syk Activation Loop Phosphospecific Antibody-- To examine the function of tyrosine phosphorylation of the Syk activation loop, we generated an antibody against a phosphopeptide based on the activation loop sequence. The serum was adsorbed by the corresponding nonphosphorylated peptide to deplete antibodies reactive with the native activation loop tyrosines. The specificity of the antibody was tested using Syk-negative mast cells reconstituted with wild type or activation loop mutant forms of Syk (21, 36). These different forms of Syk had the two tyrosines in the putative activation loop (tyrosine residues 519 and 520 of the rat sequence) mutated to phenylalanine either singly or in combination (Y519F mutant, Y520F mutant, and Y519F/Y520F mutant). The different cell lines were treated with pervanadate to induce maximum tyrosine phosphorylation of cellular proteins. Syk was then immunoprecipitated from the cell lysates with a rabbit antibody that binds a sequence in the linker region of Syk. The immunoprecipitated proteins were analyzed by immunoblotting with either mAb 4G10 that binds general phosphotyrosine residues or with the specific anti-Syk activation loop phosphotyrosine antibody (Fig. 1A). The different forms of Syk from the pervanadate treated cells gave a strong phosphorylation signal with anti-phosphotyrosine 4G10 antibody. In contrast, with the anti-phospho-AL-Syk antibody a strong signal was observed only with the wild-type Syk, while the Y519F and Y520F mutant proteins gave positive but weaker signals, and there was no signal with the Y519F/Y520F mutant. As expected, the anti-phospho-AL-Syk did not react with the nonphosphorylated Syk. Therefore, this antibody is phosphospecific for the activation loop tyrosines of Syk and does not bind to the native molecule or other phosphotyrosyl residues in Syk.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1.   Specificity of the Syk activation loop phosphospecific antibody. A Syk-negative mast cell line stably transfected with wild type or the different Syk mutants was either not stimulated or stimulated with pervanadate for 30 min. Syk was immunoprecipitated with rabbit anti-Syk, separated by SDS-polyacrylamide gel electrophoresis, and transferred to nitrocellulose for immunoblot analysis. A, immuno-blotting with anti-phosphotyrosine antibody (Anti-PY), anti-phospho- AL-Syk, or anti-Syk antibody. B, immunoblotting with anti-phosphotyrosine antibody (Anti-PY), anti-phospho-AL-Syk, and anti-phospho-AL-Syk in the presence of the synthetic peptide with either the first (pYY) or the second (YpY) tyrosine phosphorylated. The peptides were used at 0.025 nM. The different forms of Syk in these cells are as follows: wild-type (WT), Y519F (FY), Y520F (YF), and Y519F/Y520F (FF) mutants.

Synthetic phosphorylated peptides with the same backbone as that used for immunization were then used to determine whether the anti-phospho-AL-Syk antibody could distinguish the phosphorylation of each of the two adjacent tyrosines in the activation loop (Fig. 1B). These phosphopeptides with either the first or the second tyrosine phosphorylated rendered the antibody specific to the reciprocal site. For example, when a peptide with the first tyrosine phosphorylated was added to the anti-phospho-AL-Syk antibody, there was a signal only when the second tyrosine of the activation loop was phosphorylated. These experiments demonstrate that anti-phospho-AL-Syk specifically detects the phosphorylation status of both activation loop tyrosines of Syk.

Phosphorylation of Syk Activation Loop Tyrosines Correlated with Mast Cell Degranulation-- A puzzling aspect of mast cell signal transduction is that some cell stimulants, such as the anti-cell surface ganglioside mAb AA4, induce strong tyrosine phosphorylation of cellular proteins including Syk, but not histamine release (37). To investigate whether this is related to differences in the phosphorylation of the activation loop tyrosines, RBL-2H3 cells were stimulated by either IgE plus specific antigen or by mAb AA4 (Fig. 2). As had been observed previously (37) by using anti-general phosphotyrosine antibodies, both Fcepsilon RI-stimulation and mAb AA4 binding resulted in strong tyrosine phosphorylation of Syk. However, immunoblotting with anti-phospho-AL-Syk and analysis of histamine release detected marked differences with these two stimulants. Receptor aggregation with IgE plus antigen induced strong phosphorylation of the activation loop tyrosines and dramatic histamine release, while mAb AA4 binding only stimulated minor Syk activation loop tyrosine phosphorylation and minimal histamine release. To further confirm the relationship between Syk activation loop tyrosine phosphorylation and cell degranulation, RBL-2H3 cells were incubated with different concentrations of antigen or AA4 antibody, and histamine release, the total Syk and activation loop tyrosine phosphorylation determined (Fig. 3). The results were similar; after IgE plus antigen stimulation, there was histamine release together with strong tyrosine phosphorylation signals of both whole Syk and the activation loop tyrosines. In contrast, mAb AA4 binding induced only strong tyrosine phosphorylation for whole Syk. These experiments suggest that, compared with total Syk tyrosine phosphorylation, the activation loop tyrosine phosphorylation is a better indicator for Syk functional activation that leads to degranulation.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 2.   Time course of Fcepsilon RI- or anti-ganglioside mAb AA4-induced Syk tyrosine phosphorylation, the phosphorylation of the activation loop tyrosines and histamine release in the RBL-2H3 mast cells. The RBL-2H3 cells were cultured overnight with or without antigen specific IgE and then stimulated with 0.1 µg/ml antigen (cells with IgE) or 10 µg/ml mAb AA4 (cells without IgE) for the indicated times. Syk was immunoprecipitated and analyzed by immunoblotting with anti-phosphotyrosine antibody (Anti-PY), anti-phospho-AL-Syk, or mouse anti-Syk antibody. The corresponding percentage of histamine release (HR) is indicated at the bottom of each lane.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 3.   Dose responses of antigen- or mAb AA4-induced Syk tyrosine phosphorylation, the phosphorylation of the activation loop tyrosines, and histamine release in the RBL-2H3 mast cells. The RBL-2H3 cells were cultured as described in the legend of Fig. 2 and stimulated for 25 min with the indicated concentrations of antigen (cells with IgE) or mAb AA4 (cells without IgE). Syk was immunoprecipitated and analyzed by immunoblotting with anti-phosphotyrosine antibody (Anti-PY), anti-phospho-AL-Syk, or mouse anti-Syk antibody. The corresponding percentage of histamine release (HR) is indicated at the bottom of each lane.

Syk Kinase Activity Plays a Major Role in the Phosphorylation of Syk Activation Loop Tyrosines-- We then examined the role of Syk itself in the phosphorylation of its activation loop tyrosines. Syk was immunoprecipitated from nonstimulated RBL-2H3 cells and subjected to an in vitro kinase assay with or without diphosphorylated gamma -ITAM peptide (Fig. 4). As reported previously, the immunoprecipitated Syk from these quiescent cells was not tyrosine-phosphorylated but had intrinsic kinase activity, which was enhanced by the addition of diphosphorylated gamma -ITAM peptide (15). Immunoblotting with anti-phospho-AL-Syk indicated that Syk was able to phosphorylate its own activation loop tyrosines in the absence of other kinases. The addition of diphosphorylated gamma -ITAM enhanced this function. Therefore, Syk is capable of phosphorylating its activation loop tyrosines in vitro.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 4.   Syk can phosphorylate its activation loop tyrosines in vitro. Syk protein from nonstimulated RBL-2H3 cells was immunoprecipitated with rabbit anti-Syk antibody and incubated in an in vitro kinase reaction buffer containing 5 µM of ATP with or without 1 µM of diphosphorylated gamma -ITAM peptide (gamma PP) at 4 °C. After incubation for the indicated times, the precipitated Syk was analyzed by blotting with anti-phosphotyrosine antibody (Anti-PY), anti-phospho-AL-Syk, or anti-Syk antibody.

To further define the role of Syk for the in vivo phosphorylation of its own activation loop tyrosine, cells expressing wild-type Syk or kinase-dead Syk were stimulated with IgE plus specific antigen (Fig. 5). Since the extent of the tyrosine phosphorylation of kinase-dead Syk was low, we used different amounts of the cell lysates in the immunoblots to estimate the level of phosphorylation. The receptor-induced total phosphorylation of kinase-dead Syk was approximately 20% as much as that of wild type Syk; however, the activation loop tyrosine phosphorylation of kinase-dead Syk showed a more dramatic decrease (less than 10% of wild type). Therefore, in mast cells Syk plays the major role in the receptor-induced phosphorylation of its own activation loop tyrosines, while other kinases, such as Lyn, probably make minor contributions to this phosphorylation.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 5.   Syk plays a major role in the phosphorylation of its activation loop tyrosines in vivo. Syk-negative cells that had been stably transfected with the wild type (Syk-WT) or the dead kinase (Syk-DK) forms of Syk were stimulated for 20 min with 0.1 µg/ml antigen at 37 °C. Lysates from the indicated number of cells were immunoprecipitated with rabbit anti-Syk antibody and detected with anti-phosphotyrosine antibody (Anti-PY), anti-phospho-AL-Syk, or mouse anti-Syk antibody.

Both Tyrosines in the Activation Loop of Syk Are Phosphorylated in Vivo-- One of the differences between Syk and ZAP70 is that each of the two adjacent tyrosines in the activation loop of Syk is essential for propagation of receptor-induced signaling (36, 39, 40). In the present study, we noticed that after pervanadate stimulation, the 519 and 520 tyrosine residues of Syk were both phosphorylated (Fig. 1B). We then investigated the Fcepsilon RI-induced phosphorylation of the two activation loop tyrosines in wild-type Syk. After IgE plus antigen stimulation, Syk was immunoprecipitated from RBL-2H3 cells and analyzed by blotting with anti-phospho-AL-Syk antibody in the presence or absence of phosphopeptides to render it site-specific (Fig. 6). Both 519pY and 520pY peptides obviously inhibited the activation loop tyrosine phosphorylation signal. The inhibition with the two peptides demonstrates that after receptor aggregation both tyrosine residues in the activation loop are phosphorylated.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 6.   The two adjacent tyrosines in the activation loop of Syk are phosphorylated after Fcepsilon RI aggregation. The RBL-2H3 cells were cultured overnight with antigen-specific IgE and then stimulated with 0.1 µg/ml of antigen for 20 min. Syk was immunoprecipitated and analyzed by immunoblotting with anti-phospho-AL-Syk in the absence or presence of 0.025 nM of the indicated monophosphorylated peptides. The putative epitope recognized by the antibody under these conditions is indicated.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

To study the mechanism of Syk regulation by phosphorylation, an antibody was developed that was specific for the phosphorylated tyrosines in the activation loop of Syk. By using this antibody, we found that both tyrosine residues at the Syk activation loop were phosphorylated in vivo. Syk played a major role in phosphorylating these tyrosines. In antigen-stimulated cells the Fcepsilon RI-induced phosphorylation of the activation loop tyrosines paralleled the total Syk phosphorylation, and both correlated with downstream propagation of signals for histamine release. However, the cell surface binding of anti-ganglioside mAb AA4 induced only strong total Syk tyrosine phosphorylation, minimal histamine release and weak phosphorylation of the activation loop tyrosines.

Although Syk and ZAP70 belong to the same tyrosine kinase family and have many functional and structural similarities, there are differences in their signaling capacity and the mechanism of their regulation (41-43). The activation of Syk can be induced by binding to phosphorylated ITAM, while ZAP70 requires additional stimulatory input from Lck (13, 14, 44-46). In the Jurkat T cell line, Syk, but not ZAP70, can transduce T cell receptor signals independent of CD45 and of Lck (47). Similarly, in a Syk and CD45 double deficient mast cell line, the expression of Syk but not ZAP70 reconstitutes Fcepsilon RI signaling (48). In the in vitro experiments, we found that Syk phosphorylated its activation loop tyrosines probably by a trans-phosphorylation reaction. The addition of diphosphorylated ITAM peptides to immunoprecipitated Syk enhanced the rate of this phosphorylation. The results from the in vivo study also support this model. In Fcepsilon RI-activated cells, there was strong phosphorylation of the activation loop tyrosines of wild type Syk but only minimal phosphorylation at this site of the kinase-inactive Syk. Altogether, these results suggest that Syk plays a major role in phosphorylating its activation loop tyrosines, while other kinases, such as Lyn, are playing a minor contribution in this process (10).

Site-directed mutagenesis of the activation loop tyrosines of ZAP70 and Syk have demonstrated another difference between these two kinases. For ZAP70, mutation of the first activation loop tyrosine to Phe increases in vitro kinase activity and enhances the in vivo activation signal in a Syk-negative avian B cell line, whereas ZAP70 with a mutation of the second tyrosine has normal enzymatic activity but cannot transmit antigen-receptor signaling (39, 40, 44). In contrast, mutation of either one of these two tyrosines in Syk results in a loss of its capacity to function in the IgE-receptor signaling pathway, although the mutations have no effect on in vitro enzymatic activity (36). In the present study, we found that in normal RBL-2H3 cells, both tyrosines of the activation loop were phosphorylated after IgE receptor stimulation. Since in RBL-2H3 cells IgE plus antigen induced more than 60% histamine release, it appears unlikely that the phosphorylation of any one tyrosine of the activation loop plays an inhibitory role in propagating degranulation. Therefore, this observation supported the results of functional studies of Syk activation loop mutants in which it was found that if either one of the tyrosines was mutated there was loss of the signal for degranulation.

Syk contains multiple tyrosine residues, 10 of which are autophosphorylated in vitro (29). Mutagenesis of these different tyrosines has demonstrated that several of these residues are important in up- or down-regulating Syk function. For example, the putative Cbl interaction site, Tyr317, negatively regulates Syk signaling (30-33). Similarly, mutation of the three tyrosines at the COOH-terminal region of Syk results in a gain of function in T cell lines (49). In contrast, Tyr519 and Tyr520 in the activation loop of Syk are essential for propagating IgE-induced signals for degranulation (34, 36). Since the total tyrosine phosphorylation of a molecule is the sum of the phosphorylation of such sites that have positive or negative functional effects, it is not surprising that strong tyrosine phosphorylation of Syk is not always a standard for downstream propagation of signals (37). In the present experiments, we compared the Fcepsilon RI- and anti-ganglioside mAb AA4-induced histamine release to the total and activation loop tyrosine phosphorylation of Syk. We found that the phosphorylation of the activation loop tyrosines but not the total phosphorylation of Syk correlates with antigen- or AA4-mediated degranulation. Therefore, phosphorylation of the activation loop tyrosines rather than total phosphorylation is a better criterion for the functional activation of Syk.

Although mAb AA4 induced minimal tyrosine phosphorylation of the activation loop, it resulted in tyrosine phosphorylation of many cellular proteins (37). In contrast, there is minimal Fcepsilon RI-induced phosphorylation of cellular proteins in cells in which Syk activation loop tyrosines cannot be phosphorylated because they are mutated to Phe. There are several possible reasons for this difference in total cellular protein tyrosine phosphorylations. These mAb AA4-induced phosphorylations, unlike those by receptor aggregation, may not be due to Syk but my instead result from activation of other kinases such as Lyn. In fact, the ganglioside recognized by mAb AA4 is in membrane rafts and closely associated with Lyn (37). It is also possible that the low level phosphorylation of the activation loop tyrosines in mAb AA4-stimulated cells may be enough to activate Syk to propagate downstream phosphorylation of proteins; however, this cannot occur in the activation loop mutated Syk. In both mAb AA4- and receptor-stimulated cells there was strong total phosphorylation of Syk, indicating that these stimuli result in differences in the ratio of the level of phosphorylation of tyrosines in the activation loop to other sites in the molecule. The ratio in the phosphorylation of different tyrosine residues that can either up- or down-regulate Syk function could then control downstream events.

Both receptor aggregation and mAb AA4 induced strong tyrosine phosphorylation of Syk and other cellular proteins although only IgE-antigen resulted in degranulation. Total cellular tyrosine phosphorylations do not always correlate with degranulation. For example, when doubly negative CD45-/- Syk-/- cells are transfected with ZAP70 there is minimal tyrosine phosphorylation of cellular proteins without degranulation; the cotransfection with CD45 does not change this level of phosphorylation but results in degranulation (48). Another difference is that the rate of the total tyrosine phosphorylation of Syk is much slower with mAb AA4 than with receptor activation (Fig. 2). This may be critical for the organization of the complex of molecules that are important for signaling. As discussed above, the ratio in the phosphorylation of different tyrosines that can either activate or inhibit Syk function could regulate downstream signals for degranulation.

In the in vitro kinase reaction, there was autophosphorylation of Syk including phosphorylation of the activation loop tyrosines in the absence of any detectable Lyn. The binding of diphosphorylated ITAM results in a conformational change in Syk that stimulates kinase activity, thus increasing autophosphorylation (15) and the phosphorylation of the activation loop tyrosines (Fig. 4). Conformational changes in the molecule may therefore make activation loop tyrosines accessible for transphosphorylation. In vivo, there was low level phosphorylation of the activation loop tyrosines of the kinase-dead Syk, indicating the activity of another kinase, probably Lyn. These results suggest that Syk may be activated by several mechanisms that include conformational change due to ITAM binding, autophosphorylation, and phosphorylation by other kinases.

In summary, a specific, anti-Syk activation loop phosphotyrosine antibody was generated. By using this antibody, we found that both of the tyrosines in the activation loop were phosphorylated following antigen stimulation. Syk played the major role in phosphorylating its activation loop tyrosines. In Fcepsilon RI-stimulated or anti-ganglioside mAb AA4-stimulated mast cells, only phosphorylation of the activation loop tyrosines, but not the total Syk tyrosine phosphorylation, correlated with the functional response of degranulation. Therefore, the tyrosine phosphorylation of the activation loop rather than total phosphorylation of Syk is a better indicator of in vivo Syk functional activation.

    ACKNOWLEDGEMENTS

We are grateful to Dr. Kiyonao Sada and Dr. Daniel Vial for reviewing the manuscript. We thank Lynda Weedon and Greta Bader for excellent technical help.

    FOOTNOTES

* This work was supported in part by National Institutes of Health Contract NO1-DE-62614 (to M. L. B. and R. L. K.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: RAST Section, OIIB, Bldg. 10/Rm. 1N106, NIDCR, NIH, Bethesda, MD 20892. Tel.: 301-496-5105; Fax: 301-480-8328; E-mail: Lzhang@yoda.nidr.nih.gov.

Published, JBC Papers in Press, August 7, 2000, DOI 10.1074/jbc.M004549200

    ABBREVIATIONS

The abbreviations used are: ITAM, immunoreceptor tyrosine-based activation motif; mAb, monoclonal antibody; anti-phospho-AL-Syk, specific anti-Syk activation loop phosphotyrosine antibody.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Beaven, M. A., and Metzger, H. (1993) Immunol. Today 14, 222-226
2. Siraganian, R. P. (1993) in Allergy: Principles and Practice (Middleton, E. J. , Reed, C. E. , Ellis, E. F. , Adkinson, N. F. J. , Yunginger, J. W. , and Busse, W. W., eds) , pp. 105-134, Mosby-Year Book, Inc., St. Louis, MO
3. Reth, M. (1989) Nature 338, 383-384
4. Weiss, A. (1993) Cell 73, 209-212
5. Cambier, J. C. (1995) J. Immunol. 155, 3281-3285
6. Wange, R. L., and Samelson, L. E. (1996) Immunity 5, 197-205
7. Hutchcroft, J. E., Geahlen, R. L., Deanin, G. G., and Oliver, J. M. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 9107-9111
8. Benhamou, M., Ryba, N. J. P., Kihara, H., Nishikata, H., and Siraganian, R. P. (1993) J. Biol. Chem. 268, 23318-23324
9. Minoguchi, K., Benhamou, M., Swaim, W. D., Kawakami, Y., Kawakami, T., and Siraganian, R. P. (1994) J. Biol. Chem. 269, 16902-16908
10. Kurosaki, T., Takata, M., Yamanashi, Y., Inazu, T., Taniguchi, T., Yamamoto, T., and Yamamura, H. (1994) J. Exp. Med. 179, 1725-1729
11. Kihara, H., and Siraganian, R. P. (1994) J. Biol. Chem. 269, 22427-22432
12. Shiue, L., Green, J., Green, O. M., Karas, J. L., Morgenstern, J. P., Ram, M. K., Taylor, M. K., Zoller, M. J., Zydowsky, L. D., Bolen, J. B., and Brugge, J. S. (1995) Mol. Cell. Biol. 15, 272-281
13. Rowley, R. B., Burkhardt, A. L., Chao, H. G., Matsueda, G. R., and Bolen, J. B. (1995) J. Biol. Chem. 270, 11590-11594
14. Shiue, L., Zoller, M. J., and Brugge, J. S. (1995) J. Biol. Chem. 270, 10498-10502
15. Kimura, T., Sakamoto, H., Appella, E., and Siraganian, R. P. (1996) Mol. Cell. Biol. 16, 1471-1478
16. Chen, T., Repetto, B., Chizzonite, R., Pullar, C., Burghardt, C., Dharm, E., Zhao, A. C., Carroll, R., Nunes, P., Basu, M., Danho, W., Visnick, M., Kochan, J., Waugh, D., and Gilfillan, A. M. (1996) J. Biol. Chem. 271, 25308-25315
17. Rivera, V. M., and Brugge, J. S. (1995) Mol. Cell. Biol. 15, 1582-1590
18. Taylor, J. A., Karas, J. L., Ram, M. K., Green, O. M., and Seidel-Dugan, C. (1995) Mol. Cell. Biol. 15, 4149-4157
19. Scharenberg, A. M., Lin, S., Cuenod, B., Yamamura, H., and Kinet, J. P. (1995) EMBO J. 14, 3385-3394
20. Hirasawa, N., Scharenberg, A., Yamamura, H., Beaven, M. A., and Kinet, J. P. (1995) J. Biol. Chem. 270, 10960-10967
21. Zhang, J., Berenstein, E. H., Evans, R. L., and Siraganian, R. P. (1996) J. Exp. Med. 184, 71-79
22. Costello, P. S., Turner, M., Walters, A. E., Cunningham, C. N., Bauer, P. H., Downward, J., and Tybulewicz, V. L. J. (1996) Oncogene 13, 2595-2605
23. Takata, M., Sabe, H., Hata, A., Inazu, T., Homma, Y., Nukada, T., Yamamura, H., and Kurosaki, T. (1994) EMBO J. 13, 1341-1349
24. Cheng, A. M., Rowley, B., Pao, W., Hayday, A., Bolen, J. B., and Pawson, T. (1995) Nature 378, 303-306
25. Turner, M., Mee, P. J., Costello, P. S., Williams, O., Price, A. A., Duddy, L. P., Furlong, M. T., Geahlen, R. L., and Tybulewicz, V. L. (1995) Nature 378, 298-302
26. Crowley, M. T., Costello, P. S., Fitzer-Attas, C. J., Turner, M., Meng, F. Y., Lowell, C., Tybulewicz, V. J., and DeFranco, A. L. (1997) J. Exp. Med. 186, 1027-1039
27. Turner, M., Gulbranson-Judge, A., Quinn, M. E., Walters, A. E., MacLennan, I. M., and Tybulewicz, V. J. (1997) J. Exp. Med. 186, 2013-2021
28. Kiefer, F., Brumell, J., Al-Alawi, N., Latour, S., Cheng, A., Veillette, A., Grinstein, S., and Pawson, T. (1998) Mol. Cell. Biol. 18, 4209-4220
29. Furlong, M. T., Mahrenholz, A. M., Kim, K. H., Ashendel, C. L., Harrison, M. L., and Geahlen, R. L. (1997) Biochim. Biophys. Acta Mol. Cell Res. 1355, 177-190
30. Lupher, M. L., Jr., Rao, N., Lill, N. L., Andoniou, C. E., Miyake, S., Clark, E. A., Druker, B., and Band, H. (1998) J. Biol. Chem. 273, 35273-35281
31. Deckert, M., Elly, C., Altman, A., and Liu, Y. C. (1998) J. Biol. Chem. 273, 8867-8874
32. Keshvara, L. M., Isaacson, C. C., Yankee, T. M., Sarac, R., Harrison, M. L., and Geahlen, R. L. (1998) J. Immunol. 161, 5276-5283
33. Sada, K., Zhang, J., and Siraganian, R. P. (2000) J. Immunol. 164, 338-344
34. Kurosaki, T., Johnson, S. A., Pao, L., Sada, K., Yamamura, H., and Cambier, J. C. (1995) J. Exp. Med. 182, 1815-1823
35. El-Hillal, O., Kurosaki, T., Yamamura, H., Kinet, J. P., and Scharenberg, A. M. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 1919-1924
36. Zhang, J., Kimura, T., and Siraganian, R. P. (1998) J. Immunol. 161, 4366-4374
37. Swaim, W. D., Minoguchi, K., Oliver, C., Hamawy, M. M., Kihara, H., Stephan, V., Berenstein, E. H., and Siraganian, R. P. (1994) J. Biol. Chem. 269, 19466-19473
38. Basciano, L. K., Berenstein, E. H., Kmak, L., and Siraganian, R. P. (1986) J. Biol. Chem. 261, 11823-11831
39. Chan, A. C., Dalton, M., Johnson, R., Kong, G. H., Wang, T., Thoma, R., and Kurosaki, T. (1995) EMBO J. 14, 2499-2508
40. Wange, R. L., Guitian, R., Isakov, N., Watts, J. D., Aebersold, R., and Samelson, L. E. (1995) J. Biol. Chem. 270, 18730-18733
41. Couture, C., Williams, S., Gauthier, N., Tailor, P., and Mustelin, T. (1997) Eur. J. Biochem. 246, 447-451
42. Williams, B. L., Schreiber, K. L., Zhang, W. G., Wange, R. L., Samelson, L. E., Leibson, P. J., and Abraham, R. T. (1998) Mol. Cell. Biol. 18, 1388-1399
43. Fitzer-Attas, C. J., Schindler, D. G., Waks, T., and Eshhar, Z. (1998) J. Immunol. 160, 145-154
44. Kong, G. H., Dalton, M., Wardenburg, J. B., Straus, D., Kurosaki, T., and Chan, A. C. (1996) Mol. Cell. Biol. 16, 5026-5035
45. Zoller, K. E., MacNeil, I. A., and Brugge, J. S. (1997) J. Immunol. 158, 1650-1659
46. Isakov, N., Wange, R. L., Watts, J. D., Aebersold, R., and Samelson, L. E. (1996) J. Biol. Chem. 271, 15753-15761
47. Chu, D. H., Spits, H., Peyron, J. F., Rowley, R. B., Bolen, J. B., and Weiss, A. (1996) EMBO J. 15, 6251-6261
48. Zhang, J., and Siraganian, R. P. (1999) J. Immunol. 163, 2508-2516
49. Zeitlmann, L., Knorr, T., Knoll, M., Romeo, C., Sirim, P., and Kolanus, W. (1998) J. Biol. Chem. 273, 15445-15452


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
E. Tsang, A. M. Giannetti, D. Shaw, M. Dinh, J. K. Y. Tse, S. Gandhi, H. Ho, S. Wang, E. Papp, and J. M. Bradshaw
Molecular Mechanism of the Syk Activation Switch
J. Biol. Chem., November 21, 2008; 283(47): 32650 - 32659.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. W. Ng, J. di Capite, K. Singaravelu, and A. B. Parekh
Sustained Activation of the Tyrosine Kinase Syk by Antigen in Mast Cells Requires Local Ca2+ Influx through Ca2+ Release-activated Ca2+ Channels
J. Biol. Chem., November 14, 2008; 283(46): 31348 - 31355.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. E. Speich, S. Grgurevich, T. J. Kueter, A. D. Earhart, S. M. Slack, and L. K. Jennings
Platelets undergo phosphorylation of Syk at Y525/526 and Y352 in response to pathophysiological shear stress
Am J Physiol Cell Physiol, October 1, 2008; 295(4): C1045 - C1054.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. S. Yang, J. W. Seo, N. J. Han, J. Choi, K.-U. Lee, H. Ahn, S. K. Lee, and S.-K. Park
High glucose-induced NF-{kappa}B activation occurs via tyrosine phosphorylation of I{kappa}B{alpha} in human glomerular endothelial cells: involvement of Syk tyrosine kinase
Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1065 - F1075.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Leeansyah, B. D. Wines, S. M. Crowe, and A. Jaworowski
The Mechanism Underlying Defective Fc{gamma} Receptor-Mediated Phagocytosis by HIV-1-Infected Human Monocyte-Derived Macrophages
J. Immunol., January 15, 2007; 178(2): 1096 - 1104.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Wang, C. Lau, S. Wiehler, A. Pow, T. Mazzulli, C. Gutierrez, D. Proud, and C.-W. Chow
Syk Is Downstream of Intercellular Adhesion Molecule-1 and Mediates Human Rhinovirus Activation of p38 MAPK in Airway Epithelial Cells
J. Immunol., November 15, 2006; 177(10): 6859 - 6870.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Vachon, R. Martin, J. Plumb, V. Kwok, R. W. Vandivier, M. Glogauer, A. Kapus, X. Wang, C.-W. Chow, S. Grinstein, et al.
CD44 is a phagocytic receptor
Blood, May 15, 2006; 107(10): 4149 - 4158.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Lu, W.-H. Lin, S.-Y. Chen, R. Longnecker, S.-C. Tsai, C.-L. Chen, and C.-H. Tsai
Syk Tyrosine Kinase Mediates Epstein-Barr Virus Latent Membrane Protein 2A-induced Cell Migration in Epithelial Cells
J. Biol. Chem., March 31, 2006; 281(13): 8806 - 8814.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Zyss, P. Montcourrier, B. Vidal, C. Anguille, F. Merezegue, A. Sahuquet, P. H. Mangeat, and P. J. Coopman
The Syk Tyrosine Kinase Localizes to the Centrosomes and Negatively Affects Mitotic Progression
Cancer Res., December 1, 2005; 65(23): 10872 - 10880.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. M. Underhill, E. Rossnagle, C. A. Lowell, and R. M. Simmons
Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production
Blood, October 1, 2005; 106(7): 2543 - 2550.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-C. Gevrey, B. M. Isaac, and D. Cox
Syk Is Required for Monocyte/Macrophage Chemotaxis to CX3CL1 (Fractalkine)
J. Immunol., September 15, 2005; 175(6): 3737 - 3745.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Ulanova, L. Puttagunta, M. Marcet-Palacios, M. Duszyk, U. Steinhoff, F. Duta, M.-K. Kim, Z. K. Indik, A. D. Schreiber, and A. D. Befus
Syk tyrosine kinase participates in {beta}1-integrin signaling and inflammatory responses in airway epithelial cells
Am J Physiol Lung Cell Mol Physiol, March 1, 2005; 288(3): L497 - L507.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Atwell, J. M. Adams, J. Badger, M. D. Buchanan, I. K. Feil, K. J. Froning, X. Gao, J. Hendle, K. Keegan, B. C. Leon, et al.
A Novel Mode of Gleevec Binding Is Revealed by the Structure of Spleen Tyrosine Kinase
J. Biol. Chem., December 31, 2004; 279(53): 55827 - 55832.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Hitomi, J. Zhang, L. M. Nicoletti, A. C. G. Grodzki, M. C. Jamur, C. Oliver, and R. P. Siraganian
Phospholipase D1 regulates high-affinity IgE receptor-induced mast cell degranulation
Blood, December 15, 2004; 104(13): 4122 - 4128.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. M. S. Miah, K. Sada, P. T. Tuazon, J. Ling, K. Maeno, S. Kyo, X. Qu, Y. Tohyama, J. A. Traugh, and H. Yamamura
Activation of Syk Protein Tyrosine Kinase in Response to Osmotic Stress Requires Interaction with p21-Activated Protein Kinase Pak2/{gamma}-PAK
Mol. Cell. Biol., January 1, 2004; 24(1): 71 - 83.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
N. Arakaki, T. Nagao, R. Niki, A. Toyofuku, H. Tanaka, Y. Kuramoto, Y. Emoto, H. Shibata, K. Magota, and T. Higuti
Possible Role of Cell Surface H+-ATP Synthase in the Extracellular ATP Synthesis and Proliferation of Human Umbilical Vein Endothelial Cells
Mol. Cancer Res., November 1, 2003; 1(13): 931 - 939.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. Willeke, J. Schymeinsky, P. Prange, S. Zahler, and B. Walzog
A role for Syk-kinase in the control of the binding cycle of the {beta}2 integrins (CD11/CD18) in human polymorphonuclear neutrophils
J. Leukoc. Biol., August 1, 2003; 74(2): 260 - 269.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Maeno, K. Sada, S. Kyo, S. M. S. Miah, K. Kawauchi-Kamata, X. Qu, Y. Shi, and H. Yamamura
Adaptor Protein 3BP2 Is a Potential Ligand of Src Homology 2 and 3 Domains of Lyn Protein-tyrosine Kinase
J. Biol. Chem., June 27, 2003; 278(27): 24912 - 24920.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. W. Sohn, H. Gu, and S. K. Pierce
Cbl-b Negatively Regulates B Cell Antigen Receptor Signaling in Mature B Cells through Ubiquitination of the Tyrosine Kinase Syk
J. Exp. Med., June 2, 2003; 197(11): 1511 - 1524.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Faeder, W. S. Hlavacek, I. Reischl, M. L. Blinov, H. Metzger, A. Redondo, C. Wofsy, and B. Goldstein
Investigation of Early Events in Fc{epsilon}RI-Mediated Signaling Using a Detailed Mathematical Model
J. Immunol., April 1, 2003; 170(7): 3769 - 3781.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Lanham, T. Hamblin, D. Oscier, R. Ibbotson, F. Stevenson, and G. Packham
Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia
Blood, February 1, 2003; 101(3): 1087 - 1093.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Parthasarathi, H. Ichimura, S. Quadri, A. Issekutz, and J. Bhattacharya
Mitochondrial Reactive Oxygen Species Regulate Spatial Profile of Proinflammatory Responses in Lung Venular Capillaries
J. Immunol., December 15, 2002; 169(12): 7078 - 7086.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Zhang, E. Berenstein, and R. P. Siraganian
Phosphorylation of Tyr342 in the Linker Region of Syk Is Critical for Fc{varepsilon}RI Signaling in Mast Cells
Mol. Cell. Biol., December 1, 2002; 22(23): 8144 - 8154.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z.-H. Xie, I. Ambudkar, and R. P. Siraganian
The Adapter Molecule Gab2 Regulates Fc{epsilon}RI-Mediated Signal Transduction in Mast Cells
J. Immunol., May 1, 2002; 168(9): 4682 - 4691.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Merciris, M.-D. Hardy-Dessources, and F. Giraud
Deoxygenation of sickle cells stimulates Syk tyrosine kinase and inhibits a membrane tyrosine phosphatase
Blood, November 15, 2001; 98(10): 3121 - 3127.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/45/35442    most recent
M004549200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, J.
Right arrow Articles by Siraganian, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, J.
Right arrow Articles by Siraganian, R. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement